Archive for January, 2007

Fujirebo Diagnostics gets OK for test 

A Philadelphia - company got marketing approval Thursday for a blood test for mesothelioma, a form of cancer liked to asbestos exposure.
Philadelphia Business Journal
January 25, 2007
Fujirebio Diagnostics Inc., a subsidiary of Japanese company Fujirebio Inc., got Food and Drug Administration approval for its Mesomark assay test.
“The Mesomark test signifies the beginning of a new era […]

Filed:January 30th, 2007 by lmontalvo | No Comments

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma 

This study is currently recruiting patients.
Verified by Dana-Farber Cancer Institute January 2007

Sponsors and Collaborators:
Dana-Farber Cancer Institute
Massachusetts General Hospital
University of Chicago

Information provided by:
Dana-Farber Cancer Institute

ClinicalTrials.gov Identifier:
NCT00137826

Purpose
The purpose of this study is to determine whether the combination of […]

Filed:January 30th, 2007 by lmontalvo | No Comments

Mesothelioma Specialists 

Mesothelioma is an aggressive form of lung cancer resulting from exposure to asbestos. Choosing a doctor with an established reputation in treating Mesothelioma can make all the difference in your treatment experience.
A mesothelioma diagnosis is a very serious matter and understanding your treatment options is very important. That is why consulting with your primary care […]

Filed:January 17th, 2007 by lmontalvo | No Comments